Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAPKAPK5 is a serine/threonine-protein kinase that functions as a tumor suppressor and is involved in cellular stress responses. It is activated by phosphorylation through upstream MAPKs. Upon activation, it translocates from the nucleus to the cytoplasm and phosphorylates several substrates, notably heat shock protein HSP27 and FOXO3. Diseases associated with altered function or expression of MAPKAPK5 include neurocardiofaciodigital syndrome, pulmonary immaturity, and possibly Alzheimer's disease. There are also implications for cancer progression and hepatocellular carcinoma.
Phosphorylation of downstream targets, including HSP27 and FOXO3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase-activated protein kinase 5 (MAPKAPK5).